Company Filing History:
5 out of 283 
3 out of 167 
2 out of 50 
Years Active: 2004-2025
Title: The Innovations of Hans Josef Stauss
Introduction
Hans Josef Stauss is a prominent inventor based in London, GB. He has made significant contributions to the field of immunology, particularly in the development of engineered regulatory T cells. With a total of 12 patents to his name, Stauss has established himself as a leading figure in his area of expertise.
Latest Patents
Among his latest patents is the invention of an engineered regulatory T cell. This invention relates to a T cell receptor (TCR) that can specifically bind to a myelin basic protein (MBP) peptide or its variants when presented by a major histocompatibility complex (MHC) molecule. Additionally, Stauss has developed a method for enhancing the suppressive properties of Treg cells. This method focuses on increasing FOXP3 expression in a population of Tregs, thereby improving their ability to suppress immune responses.
Career Highlights
Throughout his career, Hans Josef Stauss has worked with notable companies such as UCL Business Plc and Imperial Innovations Limited. His work in these organizations has allowed him to further his research and contribute to advancements in the field of immunology.
Collaborations
Stauss has collaborated with esteemed colleagues, including Shao-An Xue and Liquan Gao. These partnerships have facilitated the exchange of ideas and fostered innovation in their shared field of research.
Conclusion
Hans Josef Stauss is a distinguished inventor whose work has significantly impacted immunology. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.